Table 3 Comparison of results of Southern Ethiopia and Kathmandu, Nepal studies
From: Evaluation of SD Bioline HIV/syphilis Duo rapid test kits in Nepal
RDT | Southern Ethiopia, 2014a | Kathmandu, Nepal, 2014b |
|---|---|---|
SD HIV/syphilis Duo | Infection | |
% Sensitivity 95 % CI | HIV 100 (98.5 to 100) | 100 % (95 % CI: 83.18–100 %) |
Syphilis 97.6 (92.4 to 99.6) | 95.45 (95 % CI: 84.86–98.74 %) | |
% Specificity % CI | HIV 99.5 (97.6 to 100) | 100 % (95 % CI: 99.96–100 %) |
Syphilis 96 (90.6 to 98.7) | 99.87 (95 % CI: 99.78–99.92 %) | |
% PPV 95 % CI | HIV 99.5 (97.6 to 100) | 100 % (95 % CI: 83.18–100 %) |
Syphilis 95.4 (89.3 to 98.5) | 76.36 (95 % CI: 63.65–85.63 %) | |
% NPV 95 % CI | HIV 100 (98.5 to 100) | 100 % (95 % CI: 99.96–100 %) |
Syphilis 98 (93.4 to 99.7) | 99.89 (95 % CI; 99.39–99.99 %) |